HackensackUMC is the First Hospital in the Nation to Receive State Approval to
Report Microbiological Clinical Results for Bacterial and Fungal
Identification Using the bioMerieux's MALDI-TOF Technology, VITEK® MS*
HACKENSACK, N.J., Dec. 20, 2012
HACKENSACK, N.J., Dec. 20, 2012 /PRNewswire-USNewswire/ --Hackensack
University Medical Center is now the first hospital in the nation to receive
state approval to report microbiological clinical results using the bioMerieux
VITEK® MS device.
"We are excited to be the first medical center in the nation approved to
report such important clinical data obtained through the VITEK MS platform,"
said Robert C. Garrett, president and chief executive officer of Hackensack
University Health Network. "HackensackUMC remains committed to staying at the
forefront of new technology and treatment methods to better care for our
patients, and the VITEK MS is another example of this commitment."
The VITEK MS is a revolutionary automated identification system for the
healthcare industry. Using MALDI-TOF Mass Spectrometry technology and a
database developed by bioMerieux for bacterial and fungal identification, the
VITEK MS provides rapid and accurate identifications. Although it is used in
other facilities across the country for research purposes, HackensackUMC
pushed technology further by seeking approval from New Jersey Department of
Health to be able to clinically report its lab results.
"The MALDI-TOF methodology incorporated into the VITEK MS platform truly
reflects a quantum leap forward in terms of accurate and extremely timely
micro-organism identification," said Ciaran Mannion, M.D., chair of the
Department of Pathology at HackensackUMC.
"We are proud to house the VITEK MS device in our Microbiology Laboratory,"
said Tao Hong, Ph.D., chief of Microbiology and Molecular Diagnostics. "The
device will not only dramatically cut the necessary time needed to receive
results, but will also cut operating costs up to 70% compared to other
traditional methods. This technology represents a significant advancement in
the clinical management of infectious disease."
[*Research Use Only]
About Hackensack University Medical Center
HackensackUMC, a non-profit teaching and research hospital located in Bergen
County, New Jersey, is the largest provider of inpatient and outpatient
services in the state, and home to the only Level II Trauma Center in the
county. This 775-bed facility has created an entire campus of care, including:
the Heart & Vascular Hospital, the John Theurer Cancer Center, the Joseph M.
Sanzari Children's Hospital, and the Donna A. Sanzari Women's Hospital.
HackensackUMC was listed as the number one hospital in New Jersey and one of
the top four New York metro area hospitals by the U.S. News & World Report,
and has received nine national rankings in: Cancer; Cardiology & Heart
Surgery; Ear, Nose & Throat; Gastroenterology; Geriatrics; Neurology &
Neurosurgery; Orthopedics; Urology; and the Joseph M. Sanzari Children's
Hospital ranked as one of the Top 25 Best Children's Hospitals for Neurology
and Neurosurgery in the 2012-13 Best Children's Hospitals list. HackensackUMC
is among HealthGrades® America's top 100 hospitals in 10 different areas –
more than any other hospital in the nation. The medical center has also been
named one of the Truven Health Analytics 100 Top Hospitals®, a Leapfrog Top
Hospital, and one of America's 50 Best Hospitals by HealthGrades® for six
years in a row. HackensackUMC received 19 Gold Seals of Approval™ by the Joint
Commission – more than any other hospital in the country. It was the first
hospital in New Jersey and second in the nation to become a Magnet® recognized
hospital for nursing excellence. HackensackUMC is the Hometown Hospital of the
New York Giants and the New York Red Bulls, and remains committed to its
community through fundraising and community events. To learn more about one of
the nation's 50 best hospitals, visit: www.HackensackUMC.org.
SOURCE Hackensack University Medical Center
Contact: Katie Grasso, +1-551-996-3780
Press spacebar to pause and continue. Press esc to stop.